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MaOBJECTIVES The purpose of this study was to investigate the prognostic value of global longitudinal strain (GLS) in
heart failure with reduced ejection fraction (HFrEF) patients in relation to all-cause mortality.
BACKGROUND Measurement of myocardial deformation by 2-dimensional speckle tracking echocardiography,
speciﬁcally GLS, may be superior to conventional echocardiographic parameters, including left ventricular ejection
fraction, in predicting all-cause mortality in HFrEF patients.
METHODS Transthoracic echocardiographic examinations were retrieved for 1,065 HFrEF patients admitted to a heart
failure clinic. The echocardiographic images were analyzed, and conventional and novel echocardiographic parameters
were obtained.
RESULTS Many of the conventional echocardiographic parameters proved to be predictors of mortality. However, GLS
remained an independent predictor of mortality in the multivariable model after adjusting for age, sex, body mass
index, total cholesterol, mean arterial pressure, heart rate, ischemic cardiomyopathy, percutaneous transluminal cor-
onary angioplasty, coronary artery bypass graft surgery, noninsulin dependent diabetes mellitus, and conventional
echocardiographic parameters (hazard ratio [HR]: 1.15; 95% conﬁdence interval [CI]: 1.04 to 1.27; p ¼ 0.008, per 1%
decrease). No other echocardiographic parameter remained an independent predictor after adjusting for these vari-
ables. Furthermore, GLS had the highest C-statistics of all the echocardiographic parameters and added incremental
prognostic value with a signiﬁcant increase in the net reclassiﬁcation improvement (p ¼ 0.009). Atrial ﬁbrillation (AF)
modiﬁed the relationship between GLS and mortality (p value for interaction ¼ 0.036); HR: 1.08 (95% CI: 0.97 to 1.19),
p ¼ 0.150 and HR: 1.22 (95% CI: 1.15 to 1.29), p < 0.001, per 1% decrease in GLS for patients with and without AF,
respectively. Sex also modiﬁed the relationship between GLS and mortality (p value for interaction ¼ 0.047); HR: 1.23
(95% CI: 1.16 to 1.30), p < 0.001 and HR: 1.09 (95% CI: 0.99 to 1.20), p ¼ 0.083, per 1% decrease in GLS for men and
women, respectively.
CONCLUSIONS GLS is an independent predictor of all-cause mortality in HFrEF patients, especially in male patients
without AF. Furthermore, GLS was a superior prognosticator compared with all other echocardiographic parameters.
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ABBR EV I A T I ON S
AND ACRONYMS
AF = atrial ﬁbrillation
CABG = coronary artery bypass
graft
CART = classiﬁcation and
regression tree
DT = deceleration time
GCS = global circumferential
strain
GLS = global longitudinal
strain
HFrEF = heart failure with
reduced ejection fraction
LAVI = left atrial volume index
LV = left ventricular
LVEF = left ventricular ejection
fraction
LVMI = left ventricular mass
index
MAP = mean arterial pressure
NIDDM = noninsulin dependent
diabetes mellitus
NRI = net reclassiﬁcation
improvement
PTCA = percutaneous
transluminal coronary
angioplasty
TAPSE = tricuspid annular
plane systolic excursion
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1352E chocardiography is the principal car-diac imaging tool used when assessingleft ventricular (LV) systolic function
in patients with heart failure (HF). Patients
with HF who have undergone an echocardio-
graphic examination have a greater chance of
survival because of intensiﬁed medical treat-
ment and intervention (1), and quantifying
LV systolic function is vital in predicting
adverse outcomes in patients with HF (2).
Two-dimensional echocardiography can be
used for evaluating LV systolic function by
obtaining left ventricular ejection fraction
(LVEF) (3). This parameter is widely used in
clinical practice (4) and has been established
as a predictor of mortality in HF patients (5).
However, a measurement of LVEF depends
on factors such as image quality, tracing
of the endocardium, and geometric ass-
umptions. Two-dimensional speckle tracking
echocardiography has in recent years emer-
ged as a method for assessing LV systolic
and diastolic function (6). The technique
measures the displacement of speckles on
the 2-dimensional echocardiographic image.
Speckle tracking offers a directional indepen-
dence of the ultrasound beam (7,8) and repre-
sents myocardial deformation rather than
volumetric change as seen by the LVEFmethod. Global longitudinal strain (GLS), obtained by
2-dimensional speckle tracking echocardiography, isSEE PAGE 1360a measurement that has previously been demon-
strated to be of prognostic value in patients having a
wide array of cardiac diseases (9). There is also evi-
dence supporting the prognostic value of GLS in HF pa-
tients (10–13). However, the previous studies on HF
were either small or did not consider alternative echo-
cardiographic predictors. Additionally, no other
studies have investigated echocardiographic risk strat-
iﬁcation models obtained by classiﬁcation and regres-
sion tree (CART) analysis and net reclassiﬁcation
improvement (NRI). The aim of this studywas to inves-
tigate the predictive value of GLS compared with con-
ventional echocardiographic parameters in predicting
mortality in a large cohort of patients with HF with
reduced LVEF (HFrEF). In addition, we sought to iden-
tify the optimal echocardiographic risk stratiﬁcation
model in this patient population.
METHODS
STUDY POPULATION. In this large-scale retrospec-
tive study, we identiﬁed 1,102 nonacute consecutivepatients referred to Gentofte Hospital’s HFrEF clinic
in the period from 2005 to 2013. Patients had an LVEF
of 45% or lower at referral. The baseline clinical data
for the patients was retrieved from the HFrEF clinic’s
database, which was registered at the patient’s ﬁrst
visit and includes history of diseases and previous
procedures performed. All patients had a diagnosis of
HFrEF by an experienced clinician and a history of
angiography to evaluate coronary artery status. The
1,102 patients were cross-referenced with the hospi-
tal’s echocardiographic database, in which an echo-
cardiographic examination was retrieved for every
patient. We included patients with an echocardio-
graphic examination performed at a maximum of
1 year from the ﬁrst admittance (median 30 days
before admittance; interquartile range [IQR]: 6 to
56 days before admittance). Twenty-two patients did
not have an echocardiographic examination within
1 year of admittance and were therefore excluded.
Furthermore, 15 patients were excluded due to a poor
or inadequate echocardiographic examination. In the
end, 1,065 patients had echocardiographic images
eligible for analysis. All clinical baseline data were
obtained on admission to the HFrEF clinic and regis-
tered by an experienced clinician. The relevant status
of medication initiated at admission date was re-
trieved from the database as well. Information on
mortality status was retrieved from the Danish Na-
tional Registry of Mortality, and follow-up was 100%.
Ischemic cardiomyopathy was deﬁned as patients
who had a history of myocardial infarction and/or
having undergone percutaneous transluminal coro-
nary angioplasty (PTCA) and/or coronary artery
bypass graft (CABG) surgery.
ECHOCARDIOGRAPHY. All the echocardiograms
were obtained using either Vivid 7 or 9 echocardio-
graphic machines (GE Healthcare, Little Chalfont,
United Kingdom). The images were stored in a GE
Healthcare image vault. The echocardiograms were
subsequently analyzed ofﬂine in Echopac version 12
(GE Healthcare) by a single investigator blinded to all
baseline patient data.
Conventional echocardiography. LVEF was obtained
using the modiﬁed Simpson rule (4). LV end-diastolic
dimensions were measured in the parasternal long-
axis view at the tip of the mitral valve leaﬂets.
These include interventricular septum thickness,
LV posterior wall dimension, and LV internal di-
mension (4).
The anatomic LV mass was estimated by the
Devereux formula (14). LV mass was then divided by
the body surface area to obtain the left ventricular
mass index (LVMI). Body surface area (m2) was
TABLE 1 Baseline Characteristics for Heart Failure Patients Alive and Those Who Died
During Follow-Up
Alive at Follow-Up
(n ¼ 888)
Dead at Follow-Up
(n ¼ 177) p Value
Age, yrs 66  12 72.5  9 <0.001
Heart rate, beats/min 74  16 78  18 0.002
BMI, kg/m2 26.6  5 25.8  5 0.028
MAP, mm Hg 94  13 89  14 <0.001
Cholesterol, mmol/l 4.5  1 4.3  1 0.014
Atrial ﬁbrillation/atrial ﬂutter 127 (14) 45 (25) <0.001
Male 648 (73) 136 (77) 0.29
History of MI 408 (46) 88 (50) 0.36
Angina pectoris 195 (22) 49 (28) 0.098
IDDM 17 (2) 5 (3) 0.44
NIDDM 78 (9) 28 (16) 0.004
PTCA 267 (30) 32 (18) 0.001
CABG 175 (20) 48 (27) 0.027
Pacemaker 45 (5) 14 (8) 0.13
Implantable cardioverter-deﬁbrillator 23 (3) 6 (3) 0.55
ICM 503 (57) 105 (59) 0.51
RAS blockade 709 (80) 137 (77) 0.46
Beta-blocker 590 (66) 120 (68) 0.73
Spironolactone 132 (15) 22 (12) 0.50
Diuretic 462 (52) 81 (46) 0.12
Anticoagulants 168 (19) 33 (19) 0.93
Antiarrhythmics 40 (5) 9 (5) 0.74
Calcium channel blocker 8 (1) 1 (1) 0.66
Values are mean  SD or n (%).
BMI ¼ body mass index; CABG ¼ coronary artery bypass graft; ICM ¼ ischemic cardiomyopathy;
IDDM ¼ insulin-dependent diabetes mellitus; MAP ¼ mean arterial pressure; MI ¼ myocardial infarction;
NIDDM ¼ noninsulin-dependent diabetes mellitus; PTCA ¼ percutaneous transluminal coronary angioplasty;
RAS ¼ renin-angiotensin system.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 1 2 , 2 0 1 5 Sengeløv et al.
D E C E M B E R 2 0 1 5 : 1 3 5 1 – 9 Global Strain Predicts Mortality in HFrEF
1353obtained using the Du Bois formula (15). Left atrial
volume was measured by the area length method and
divided by the body surface area to estimate the left
atrial volume index (LAVI) (4).
The tricuspid annular plane systolic excursion
(TAPSE) was measured using M-mode echocardiog-
raphy in the 4-chamber apical view to determine the
lateral tricuspid annulus motion.
Pulsed-wave Doppler in the 4-chamber apical view
was used to assess mitral valve inﬂow patterns and
obtain the peak velocities of early diastolic left ven-
tricular ﬁlling (E) and atrial diastolic left ventricular
ﬁlling (A). We also calculated the E/A ratio and
measured the deceleration time (DT) of the E-wave.
With the sample volume placed at the septal and
lateral mitral annular sites in the 4-chamber apical
view, pulsed-wave tissue Doppler imaging was used
to measure the peak longitudinal early diastolic (e0)
tissue velocity. The mean value was calculated as an
average between the septal and lateral velocities. To
assess LV ﬁlling pressure, we calculated the E/e0 (16).
Speckle tracking echocardiography. Two-dimensional
speckle tracking analysis was performed in the 2-, 3-,
and 4-chamber apical views with an average of 74 
18 frames/s. The endocardial border was traced by
an automated function that deﬁned a region of in-
terest (ROI) at end-systole. The investigator visually
assessed the detected ROI and, if necessary, manually
modiﬁed the ROI to ensure correct tracking of the
speckles. Tracking was satisfactory if it covered the
entire cardiac wall from the endocardium through to
the myoepicardial border and if there was a visible
motion of the speckles. In case of poor speckle
tracking, the ROI was readjusted. A segment was
excluded if it did not fulﬁll these criteria or were
compromised by a shadow or artifact. In this case, the
automatic quality score was also ignored. GLS was
calculated as an average of the 3 apical projections
and the ROI set to cover the entire left ventricle. If
speckle tracking could not be obtained from a cham-
ber view, GLS was averaged from the 2 remaining
chamber views (total 4-chamber views: 996; 2-
chamber views: 1,009; and apical long-axis views:
922). The peak GLS rate was calculated using the same
approach as that for GLS.
Circumferential speckle tracking was analyzed in
the parasternal short-axis view at the midventricular
level, and we calculated global circumferential strain
(GCS) and GCS rate.
STATISTICAL ANALYSIS. SPSS version 19.0 (IBM,
Chicago, Illinois), STATA version SE 12.0 (StataCorp,
College Station, Texas), and R software version 2.15.2
(R Foundation for Statistical Computing, Vienna,
Austria) were used for statistical analysis. For allanalyses performed, a p value in a 2-sided test <0.05
was considered statistically signiﬁcant.
The continuous variables were compared using
the Student t test. The chi-square test was used if
the variable was categorical. Survival curves were
constructed using the Kaplan-Meier method. Cox
proportional hazards regression models were con-
structed, and both univariable and multivariable
hazard ratios (HRs) were calculated. The assumption
of proportional hazards were graphically asserted and
tested based on the Schoenfeld residuals. In the
multivariable regression models, we included sex,
ischemic cardiomyopathy, and the baseline charac-
teristics that were signiﬁcant predictors of mortality:
age, sex, body mass index, mean arterial pressure
(MAP), total cholesterol, heart rate, noninsulin-
dependent diabetes mellitus (NIDDM), PTCA, CABG
(Table 1), and signiﬁcant echocardiographic parame-
ters (LVEF, LVMI, LAVI, E, E/e0, E/A ratio, DT, and
TAPSE) (Table 2). Every strain parameter (GLS,
GLS rate, GCS, and GCS rate) was assessed individu-
ally in the multivariable regression model to avoid
multicollinearity.
TABLE 2 Conventional Echocardiographic and 2-Dimensional Speckle Tracking
Parameters of Heart Failure Patients Alive and Deceased at the Date of Follow-Up
Echocardiographic Parameters
Alive at Follow-Up
(n ¼ 888)
Dead at Follow-Up
(n ¼ 177) p Value
LVEF, % (888;177) 28.2  9.1 23.8  9.9 <0.001
LVIDd, cm (882;177) 5.6  1.0 5.7  1.1 0.27
LVMI, g/m2 (888;177) 117  37 122  38 0.040
LAVI, ml/m2 (870;175) 30  13 38  19 <0.001
E, m/s (856;166) 0.8  0.3 0.9  0.3 0.002
A, m/s (741;124) 0.7  0.3 0.7  0.3 0.124
E/A, (740;124) 1.4  1.0 1.7  1.2 0.05
DT, ms (850;166) 191  80 176  71 0.025
e0, cm/s (806;157) 6.9  2.5 6.7  2.6 0.35
E/e0 (797;155) 12.8  6.0 14.7  6.7 0.002
TAPSE, cm (888;177) 1.9  0.6 1.6  0.6 <0.001
GLS rate, 1/s (846;166) 0.6  0.3 0.5  0.2 <0.001
GCS rate, 1/s (760;138) 0.6  0.3 0.5  0.3 0.25
GCS, % (728;136) 10.6  4.06 9.1  4.5 <0.001
GLS, % (878;176) 9.9  3.2 8.1  3.0 <0.001
Values are mean  SD and the values in parentheses specify patients with measurement available for the speciﬁc
parameter.
A ¼ peak transmitral late diastolic inﬂow velocity; DT ¼ deceleration time of early diastolic ventricular inﬂow;
E ¼ peak transmitral early diastolic inﬂow velocity; e0 ¼ average peak early diastolic mitral annular velocity;
GCS ¼ global circumferential strain; GLS ¼ global longitudinal strain; LAVI ¼ left atrial volume index; LVEF ¼ left
ventricular ejection fraction; LVIDd ¼ left ventricular internal dimension in diastole; LVMI ¼ left ventricular mass
index; TAPSE ¼ tricuspid annular plane systolic excursion.
FIGURE 1 Kaplan-Meier Curves for Patients Stratiﬁed Into
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1354To assess the prognostic strength of the examined
parameters, Harrell C statistics were calculated from
the univariable Cox regression models.
Using logistic regression, models were constructed
for predicting the risk of future mortality in patients
during follow-up of 40 months (IQR: 22 to 57 months).
Reclassiﬁcation analysis by arbitrary risk categories
of <5%, 5% to <30%, 30% to <50%, and $50% was
performed to assess NRI when adding GLS or LVEF to
the signiﬁcant clinical and echocardiographic pre-
dictors of mortality in the population.
We also performed a CART analysis (17) to identify
the optimal echocardiographic risk stratiﬁcation for
HFrEF patients and all-cause mortality. CART anal-
ysis is an empirical, statistical technique based on
recursive partitioning of the data space to predict the
response (17). The models are obtained by binary
splitting of the data by the value of predictors, and
the split variable and split-point are automatically
selected from possible predictive values to achieve
the best ﬁt. Then, 1 or both “child nodes” are split into
2 or more regions recursively, and the process con-
tinues until a stopping rule is applied. Finally, the
result of this process is represented as a binary deci-
sion tree.
ETHICS. The study was approved by the Danish Data
Protection Agency, journal no. 03240 (I-Suite), ID:
GEH-2014-047.RESULTS
PREDICTORS OF ALL-CAUSE MORTALITY IN
PATIENTS WITH HFrEF. During a median follow-up
of 40 months (IQR: 22 to 57 months), 177 patients
(16.7%) died.
Patients who died during follow-up were signiﬁ-
cantly older, had lower MAP, higher heart rate, and
lower total cholesterol. There were a higher propor-
tion of patients with NIDDM and of patients who had
CABG surgery and PTCA performed (Table 1).
With regard to the echocardiographic examination,
patients who died during follow-up had signiﬁcantly
lower LVEF, GLS, GCS, and GCS rate. Patients who died
had larger LVMI, larger LAVI, lower TAPSE, higher
peak inﬂow E-wave velocity, shorter DT of early mitral
inﬂow, higher E/A ratio and higher E/e0 ratio (Table 2).
The patient population was stratiﬁed into tertiles
of GLS. The risk of dying increased with decreasing
tertile of GLS, being approximately 3 times higher for
patients in the lowest tertile compared with patients
in the highest tertile (tertile 1 vs. tertile 3, HR: 3.38,
95% CI: 2.3 to 5.1, p < 0.001) (Figure 1). In the multi-
variable Cox regression, GLS was the only echocar-
diographic parameter that was an independent
predictor of mortality: HR 1.15 (95% CI: 1.04 to 1.27),
p ¼ 0.008) per 1% decrease (Table 3). Further analysis
with multivariable models including medication
(Online Table 1) and tissue Doppler imaging parame-
ters (Online Table 2) did not inﬂuence the prognostic
signiﬁcance of GLS. In addition, GLS was the param-
eter with highest Harrell C-statistics of all the
TABLE 3 Univariable and Multivariable Cox Proportional Hazard Models
Univariable Analysis
C-Statistic
Multivariable Analysis*
HR 95% CI p Value HR 95% CI p Value
Age, per 1-yr increase 1.05 1.03–1.06 <0.001 1.05 1.02–1.07 <0.001
MAP, per 1-mm Hg increase 0.97 0.96–0.98 <0.001 0. 97 0.95–0.98 <0.001
Heart rate, per 1-beat/min decrease 1.01 1.00–1.02 0.015
Ischemic cardiomyopathy 1.14 0.84–153 0.39 1.32 0.78–2.26 0.305
CABG 1.41 1.01–1.96 0.043
PTCA 0.56 0.38–0.82 0.003
Cholesterol, per 1-mmol/l increase 0.83 0.72–0.96 0.013
NIDDM 1.88 1.25–2.81 0.002 2.66 1.55–4.30 <0.001
BMI, per 1-kg/m2 increase 0.97 0.93–0.99 0.036
LVEF, per 1% increase 0.95 0.94–0.97 <0.001 0.6533
LVMI, per 1-g/m2 decrease 1.04 1.00–1.01 0.036 0.5641
LAVI, per ml/m2 decrease 1.02 1.01–1.03 <0.001 0.6048
TAPSE, per 1-cm increase 0.44 0.34–0.58 <0.001 0.6319
E, per 1-m/s increase 1.88 1.20–2.96 0.006 0.5694
DT, per 1-ms decrease 0.99 0.99–1.00 0.031 0.5638
E/A, per 1 increase 1.23 1.08–1.41 0.003 0.5709
e0, per 1-cm/s increase 0.004 0.00–1.96 0.08 0.5502
E/e0, per 1 decrease 1.06 1.02–1.06 0.001 05902
GCS rate, per 1-s1 decrease 1.85 0.96–3.60 0.067 0.5833
GCS, per 1% decrease 1.11 1.06–1.16 <0.001 0.6371
GLS rate, per 1-s1 decrease 11.02 4.64–26.20 <0.001 0.6450
GLS, per 1% decrease 1.20 1.14–1.26 <0.001 0.6735 1.15 1.04–1.27 0.008
*Multivariable model includes age, sex, BMI, total cholesterol, MAP, heart rate, Ischemic cardiomyopathy, PTCA, CABG, NIDDM, LVEF, LVMI, LAVI, TAPSE, DT, E velocity,
E/e0 ratio, E/A ratio, and GLS. Only HRs for variables that are signiﬁcant in the multivariable analysis are shown.
CI ¼ conﬁdence interval; HR ¼ hazard ratio; other abbreviations as in Tables 1 and 2.
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1355echocardiographic parameters. Only age, MAP, and
NIDDM also remained independent predictors of
mortality in the multivariable model.
PROGNOSTIC UTILITY OF GLS IN RELATION TO SEX
AND THE PRESENCE OF ATRIAL FIBRILLATION. A
substantial proportion of the patient population who
were deceased at follow-up had atrial ﬁbrillation (AF)
(25.4%). We therefore sought to investigate whether
GLS could be used to predict mortality in patients
with AF. We found that AF modiﬁed the relationship
between GLS and mortality (p value for interaction ¼
0.036). From the Cox regression we estimated an HR
of 1.08 (95% CI: 0.97 to 1.19; p ¼ 0.150) and an HR of
1.22 (95% CI: 1.15 to 1.29; p < 0.001) per 1% decrease in
GLS for patients with and without AF, respectively
(Online Figures 1A and 1B). We also performed a
subgroup analysis of the AF patients to investigate
whether the GLS rate would be a better prognosti-
cator. In the univariable Cox regression, the GLS rate
did not signiﬁcantly predict mortality (p ¼ 0.07);
however, LVEF did (p ¼ 0.014). None was signiﬁcant
in the multivariable model.
Sex also modiﬁed the relationship between GLS and
mortality (p value for interaction ¼ 0.047; HR: 1.23[95% CI: 1.16 to 1.30; p < 0.001] and HR: 1.09 [95% CI:
0.99 to 1.20; p¼0.083]) per 1% decrease in GLS for men
and women, respectively (Online Figures 1C and 1D).
In a subgroup analysis including only male pa-
tients without AF (n ¼ 510), GLS remained an inde-
pendent predictor of mortality in the multivariable
model: HR: 1.16 (95% CI: 1.03 to 1.31; p ¼ 0.010) per 1%
decrease in GLS including the same covariates as listed
in Table 3.
INCREMENTAL PROGNOSTIC VALUE OF ADDING
GLS IN RELATION TO PREDICTING MORTALITY.
Adding GLS to the signiﬁcant clinical parameters
(age, sex, MAP, NIDDM, PTCA, CABG, body mass in-
dex, heart rate, total cholesterol) and the conven-
tional echocardiographic parameters (LVEF, LVMI,
LAVI, TAPSE, E, DT, E/A, E/e0) resulted in an
improved prediction model with a signiﬁcant increase
in the categorical NRI of 9.27% (95% CI: 9.18% to
9.36%; p ¼ 0.009) (Online Table 3). A similar result
was found when conﬁning the analysis to male pa-
tients without AF (NRI of 8.26%, 95% CI: 8.17% to
8.34%; p ¼ 0.040) (Online Table 4). In comparison,
adding LVEF to the same model did not result in a
better predicting model (p ¼ 0.38).
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1356ECHOCARDIOGRAPHIC RISK
STRATIFICATION IN PATIENTS WITH HFrEF
Performing a CART analysis including all the echocar-
diographic parameters resulted in the risk stratiﬁca-
tion tree depicted in Figure 2. The statistical
stratiﬁcation obtained by the CART analysis demon-
strated that GLS is especially useful for stratifying pa-
tientswith very severeHF as deﬁned by an LVEF<22%.
Even though GLS seems to be the single-handedly
strongest echocardiographic prognosticator in HFrEF,
the optimal echocardiographic risk stratiﬁcation
strategy includes an evaluation of several echocar-
diographic predictors (TAPSE, LVEF, E, and GLS).
DISCUSSION
The present study is, as far as the authors are aware,
the largest study determining the prognostic utility ofatiﬁcation Tree Using LVEF, GLS, E, and TAPSE as Obtained by CART Analy
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ic excursion.GLS in patients with HFrEF. We demonstrate that GLS
seems to be a superior prognosticator compared with
all other conventional echocardiographic parameters.
In addition, we found GLS to be of limited prognostic
value in females and patients with AF. GLS also resul-
ted in a better risk predictionmodel when added to the
baseline clinical risk factors and echocardiographic
parameters. Finally, we provide an echocardiographic
risk stratiﬁcation tree that allocates patients with
HFrEF into several clearly deﬁned risk groups.
PROGNOSTIC VALUE OF GLS IN RELATION TO
MORTALITY. Our ﬁndings are consistent with most
previous studies conducted examining GLS in rela-
tion to all-cause mortality (11–13,18). However, we
demonstrate that GLS is not only superior to the
systolic echocardiographic parameter in predicting
mortality, but also preferable to conventional echo-
cardiographic parameters, as reﬂected by the highestsis
TAPSE
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TAPSE
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GLS
≥ 5.9%
GLS
< 5.9%
LVEF
< 22%
lity 20%
/159)
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VEF, GLS, E, and TAPSE combined. All echocardiographic parameters
icted in the risk stratiﬁcation tree. CART ¼ classiﬁcation and regression
art failure; LVEF ¼ left ventricular ejection fraction; TAPSE ¼ tricuspid
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1357C-statistic value. In addition, GLS as the only echo-
cardiographic parameter remained an independent
predictor of mortality after adjustment for all the
univariable predictors. However, compared with
other studies, our study did not include data on New
York Heart Association functional class.
Our results are the ﬁrst to demonstrate an incre-
mental predictive value of adding GLS to established
risk factors. NRI analysis yielded a signiﬁcant reallo-
cation of patients in the respective risk groups
(Online Table 3). This was not the case when adding
LVEF to a model already including GLS (p ¼ 0.38).
Therefore, LVEF does not improve our risk prediction
model if an assessment of GLS has already been per-
formed. This ﬁnding, together with GLS having a
higher C-statistic and being the only signiﬁcant echo-
cardiographic parameter in the multivariable model,
suggests that GLS is a superior systolic prognosticator.
Nevertheless, in accordance with the risk stratiﬁcation
tree obtained from our CART analysis, an assessment
of both LVEF andGLS is especially useful in identifying
high-risk patients (Figure 2). Thus, our results do not
suggest using GLS as a replacement for conventional
echocardiographic predictors, but rather that an
assessment of GLS conveys detailed information about
the LV systolic function and adds information on the
risk of mortality beyond the information that we can
gain from our conventional measures.
Another factor to consider is that the images used
in the present study were retrieved from a clinical
examination. Our study reﬂects the quality obtained
in the daily clinical practice. This could suggest that
GLS can be used in the clinical setting to predict
mortality and is a more robust method than previ-
ously considered.
In the present report, we are the ﬁrst to incorporate
GLS in a risk stratiﬁcation tree, together with the
conventional echocardiographic measurements, as
depicted in the CART analysis (Figure 2). Because it
can be difﬁcult to interpret isolated GLS values, this
risk stratiﬁcation tree gives a very simple decision
algorithm for the clinician to place HFrEF patients in
risk categories. This information could prove valuable
in the clinical setting and potentially optimize certain
aspects of HF treatment plans. In addition, the algo-
rithm could prove useful as a research tool when
initiating new clinical trials of HF drugs or devices to
identify high-risk patients.
GCS has previously been proved to be a better
prognosticator than both LVEF and GLS (19). In our
study, we found GCS to be a signiﬁcant predictor of
mortality in the univariable analysis. When we
adjusted for the baseline characteristics and con-
ventional echocardiographic parameters, GCS didnot remain an independent predictor of mortality
(Table 3). We also examined GCS and GLS rate pa-
rameters to see whether the deformation velocities
added any incremental value in predicting mortality.
These parameters proved to be signiﬁcant in the
univariable models but failed to be signiﬁcant in the
multivariable model (Table 3).
GLS AS A PREDICTOR OF MORTALITY IN FEMALE
HFrEF PATIENTS WITH AF. This study is the ﬁrst
to demonstrate the interaction between AF and GLS
in predicting mortality in HFrEF. GLS was not a sig-
niﬁcant predictor of mortality in patients with AF
(Online Figure 1A).
Patients with AF have higher heart rates (20), and
this was also the case in our study, with a signiﬁcant
difference in heart rate for patients without AF
(73.1  15.0 beats/min) and patients with AF (80  21
beats/min) (p < 0.001). The increased heart rate will
cause a lower stroke volume and consequently a
lower GLS. Another hemodynamic consequence of AF
is the beat-to-beat variations of the systolic perfor-
mance that could affect the GLS measurements (21).
Together these factors may contribute to a systematic
underestimation of GLS and thus explain the limited
prognostic capability of GLS in AF patients. This
underestimation could possibly be bypassed by re-
cording up to 10 cardiac cycles to ensure that the GLS
measurement is representative of the true peak value.
We also found that sex modiﬁed the relationship
between GLS and mortality in HFrEF. GLS did not
predict mortality in women (Online Figure 1C). It is
known that women have a signiﬁcantly lower amount
of cardiac muscle mass as measured by LVMI (22,23)
and lower volumetric measurements (4). LVEF has
also been demonstrated to be higher in women
(24,25) as has GLS (26). Even though we found some
signiﬁcant differences between men and women
(Online Table 5), these differences do not explain the
marked difference in the prognostic capability of GLS
in men and women. Nevertheless, our differences in
echocardiographic measurements between men and
women are in accordance with those of previous
studies (22–26). Together, these ﬁndings may indicate
an intrinsic difference in the cardiac architecture,
physiology, and LV systolic performance between
men and women. This information must be taken into
account when making sex-speciﬁc risk stratiﬁcation
of HFrEF patients, but further studies are needed to
clarify the exact underlying mechanism of the cardiac
differences between sexes. In both the multivariable
analysis (Table 3) and NRI analysis (Online Tables 3
and 4), GLS remained a signiﬁcant and incremental
predictor of mortality even when conﬁning our anal-
ysis to include only men without AF.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE 1: GLS
has previously been shown to predict outcome in
heart failure. This study shows that GLS is a powerful
predictor of mortality compared with all the con-
ventional echocardiographic parameters in HFrEF.
The use of GLS to identify patients at high risk of
mortality could lead to changes in follow-up or
therapy.
COMPETENCY IN MEDICAL KNOWLEDGE 2: It is
important when risk-stratifying HFrEF patients to
make a comprehensive echocardiographic assessment
of the entire heart, which includes systolic, diastolic,
and right heart function.
TRANSLATIONAL OUTLOOK: This study provides
new information on prognosis and sex-speciﬁc dif-
ferences of GLS. Additional research is needed to
validate this ﬁnding and clarify a possible physiolog-
ical explanation for the sex differences.
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1358STUDY LIMITATIONS. There are several limitations of
this study, which should be taken into consideration.
The time from admittance to the HFrEF clinic to the
echocardiographic examination was in some patients
relatively long (up to a year). Under optimal circum-
stances, the echocardiographic examinations would
have been performed on the same day as the patients
were admitted to reﬂect the in-clinic cardiac perfor-
mance. However, the large majority of patients had
their echocardiographic examination performed very
near to the admission to the heart failure clinic (me-
dian 30 days before admittance; IQR: 6 to 56 days
before admittance). In addition, we performed a
sensitivity analysis including patients with an echo-
cardiographic examination within 3 months before
admission, which yielded the same results as those
seen when using our inclusion criteria.
Our study did not account for clinical characteris-
tics such as New York Heart Association functional
class and brain natriuretic peptide, which have been
shown to be of importance when assessing the prog-
nosis in HFrEF (11,27). In addition, patients’ medica-
tions were registered at admission to the heart failure
clinic, but adjustments of the treatment after con-
secutive visits to the heart failure clinic could affect
both mortality and GLS.
As this study was retrospective and performed in a
clinical setting, we were only able to retrieve a single
cardiac cycle and could not obtain information on
QRS duration, serum creatinine, and cardiac re-
synchronization therapy. Lastly, we only calculated
GCS from the papillary muscle level. GCS obtained
from other views might have improved the predictive
value of GCS.
CONCLUSIONS
In the present study, we found GLS to be a strong
prognosticator of all-cause mortality in patients with
HFrEF. Additionally, GLS was superior to LVEF and
all other conventional echocardiographic parametersin predicting mortality. However, GLS was not a sig-
niﬁcant prognosticator of mortality in HFrEF patients
with AF or in women. Furthermore, GLS provided
incremental prognostic information when added to
a model already including signiﬁcant echocardio-
graphic and clinical predictors. Finally, the optimal
echocardiographic risk stratiﬁcation tree in HFrEF
patients includes an assessment of measures of sys-
tolic (LVEF and GLS), diastolic (E), and right ventric-
ular (TAPSE) function.
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